129 related articles for article (PubMed ID: 27053566)
21. Update on research and development pipeline: tuberculosis vaccines.
Beresford B; Sadoff JC
Clin Infect Dis; 2010 May; 50 Suppl 3():S178-83. PubMed ID: 20397946
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in tuberculosis vaccines.
Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
Expert Rev Vaccines; 2013 Dec; 12(12):1431-48. PubMed ID: 24195481
[TBL] [Abstract][Full Text] [Related]
23. Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?
Smaill F; Xing Z
Expert Rev Vaccines; 2014 Aug; 13(8):927-30. PubMed ID: 24935214
[TBL] [Abstract][Full Text] [Related]
24. Protegen: a web-based protective antigen database and analysis system.
Yang B; Sayers S; Xiang Z; He Y
Nucleic Acids Res; 2011 Jan; 39(Database issue):D1073-8. PubMed ID: 20959289
[TBL] [Abstract][Full Text] [Related]
25. Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
Orme IM
Vaccine; 2006 Jan; 24(1):2-19. PubMed ID: 16139397
[TBL] [Abstract][Full Text] [Related]
26. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
27. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
Xing Z; Charters TJ
Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
[TBL] [Abstract][Full Text] [Related]
28. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
29. A new TB vaccine: fact or fiction?
van Helden PD; Hoal EG
Comp Immunol Microbiol Infect Dis; 2013 May; 36(3):287-94. PubMed ID: 22921282
[TBL] [Abstract][Full Text] [Related]
30. Prospects for a novel vaccine against tuberculosis.
Dietrich J; Weldingh K; Andersen P
Vet Microbiol; 2006 Feb; 112(2-4):163-9. PubMed ID: 16325357
[TBL] [Abstract][Full Text] [Related]
31. Tuberculosis vaccines and prevention of infection.
Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
[TBL] [Abstract][Full Text] [Related]
32. [Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis].
Azaev MSh; Lebedev LR; Kuz'micheva GA; Tumanov IuV; Donchenko NA; Tat'kov SI; Nosareva OV; Il'ichev AA
Probl Tuberk Bolezn Legk; 2007; (2):38-42. PubMed ID: 17419334
[TBL] [Abstract][Full Text] [Related]
33. Creativity in tuberculosis research and discovery.
Younga D; Verreck FA
Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S14-6. PubMed ID: 22441152
[TBL] [Abstract][Full Text] [Related]
34. Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccination.
Orme IM
Tuberculosis (Edinb); 2006 Jan; 86(1):68-73. PubMed ID: 16260181
[TBL] [Abstract][Full Text] [Related]
35. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
Sable SB; Kalra M; Verma I; Khuller GK
Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
[TBL] [Abstract][Full Text] [Related]
36. Fact and fiction in tuberculosis vaccine research: 10 years later.
Kaufmann SH
Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
[TBL] [Abstract][Full Text] [Related]
37. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
[TBL] [Abstract][Full Text] [Related]
38. Replacing, reducing and refining the use of animals in tuberculosis vaccine research.
Tanner R; McShane H
ALTEX; 2017; 34(1):157-166. PubMed ID: 27667476
[TBL] [Abstract][Full Text] [Related]
39. The present and future of tuberculosis vaccinations.
Principi N; Esposito S
Tuberculosis (Edinb); 2015 Jan; 95(1):6-13. PubMed ID: 25458613
[TBL] [Abstract][Full Text] [Related]
40. A coordinated strategy for evaluating new vaccines for human and animal tuberculosis.
McMurray DN
Tuberculosis (Edinb); 2001; 81(1-2):141-6. PubMed ID: 11463235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
